FDA Adverse Event Other Summary report: N

HYDRELLE

MDR report key: 2001131 · Received February 18, 2011

Report

Report Number
1223628-2011-00006
Event Type
Other
Date Received
February 18, 2011
Date of Event
August 24, 2010
Report Date
February 18, 2011
Manufacturer
ANIKA THERAPEUTICS, INC
Product Code
LMH
PMA / PMN Number
050033
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
AL, US
Reporter Occupation
NOT APPLICABLE

Narratives

Additional Manufacturer Narrative · 1

PER PRODUCT LABELING, THE PRODUCT IS INDICATED FOR USE IN THE MID TO DEEP DERMIS FOR THE CORRECTION OF MODERATE TO SEVERE FACIAL WRINKLES AND FOLDS SUCH AS NASOLABIAL FOLDS.

Description of Event or Problem · 1

PT WAS INJECTED IN THE NLF'S ON (B)(6) 2010, A CYSTIC NODULE OCCURRED AT THE TIME OF THE INJECTION. THE PT DID NOT SEEK TREATMENT AT THE TIME. THE CYST CONTINUED TO ENLARGE GRADUALLY. THE PT WENT TO THE PHYSICIAN IN (B)(6) AND THE PHYSICIAN ASPIRATED THE CYST. PT IS STABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 HYDRELLE IMPLANT, DERMAL FOR AESTHETIC USE LMH ANIKA THERAPEUTICS, INC 685-015 V090044BA

Patients

Seq Age Sex Outcome Treatment
1 60 YR Required Intervention